Cite

HARVARD Citation

    Gomberg‐Maitland, M. et al. (2015). Phase I Safety Study of Ranolazine in Pulmonary Arterial Hypertension. Pulmonary circulation. pp. 691-700. [Online]. 
  
Back to record